Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
51,136,131
-
Number of holders
-
86
-
Total 13F shares, excl. options
-
20,796,965
-
Shares change
-
+4,875,716
-
Total reported value, excl. options
-
$401,380,019
-
Value change
-
+$94,928,884
-
Number of buys
-
54
-
Number of sells
-
-30
-
Price
-
$19.3
Significant Holders of REGENXBIO Inc. - Common Stock, par value $0.0001 per share (RGNX) as of Q1 2017
95 filings reported holding RGNX - REGENXBIO Inc. - Common Stock, par value $0.0001 per share as of Q1 2017.
REGENXBIO Inc. - Common Stock, par value $0.0001 per share (RGNX) has 86 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 20,796,965 shares
of 51,136,131 outstanding shares and own 40.67% of the company stock.
Largest 10 shareholders include BlackRock Inc. (2,380,591 shares), FMR LLC (2,274,594 shares), Bain Capital Public Equity Management, LLC (1,893,311 shares), PERCEPTIVE ADVISORS LLC (1,396,244 shares), Redmile Group, LLC (1,269,131 shares), RTW INVESTMENTS, LP (1,216,505 shares), JPMORGAN CHASE & CO (1,175,794 shares), VANGUARD GROUP INC (981,517 shares), FRANKLIN RESOURCES INC (973,200 shares), and Partner Fund Management, L.P. (798,247 shares).
This table shows the top 86 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.